Comment on a recent article titled “Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals”

Reply to the comments of Naharci et al. on “Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals”

“…We appreciate Naharci et al 1 for their interest and constructive comments on our recent article 2 , which investigated associations between metabolic dysfunction-associated fatty liver disease (MAFLD) and fatty acid-binding protein 4 (FABP4) in a Japanese general population. In their recent letter to the editor, the authors claimed that physical activity level and renal function were not taken into consideration as potential confounders 1 .…”